To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease
NCT ID: NCT05858138
Last Updated: 2025-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2022-05-03
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study the Impact of Hirsutella Sinensis Nutrient Supplements Has on Improving Muscle Health and Metabolism in Elderly
NCT05284149
Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma
NCT00155103
Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular Carcinoma
NCT00629486
Increased Tea Consumption is Associated With a Decreased Risk of Renal Stone Disease in a Taiwanese Population
NCT03318926
The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques
NCT05225454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Jing-Si Herbal Tea group
Each patient will receive Jing-Si Herbal Tea two times (after breakfast and lunch) in a day for 24 weeks.
Jing-Si Herbal Tea
patient will receive twice in a day for 24 weeks
Placebo group
Each patient will receive placebo two times (after breakfast and lunch) in a day for 24 weeks.
Placebo Jing-Si Herbal Tea
Placebo Jing-Si Herbal Tea
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Jing-Si Herbal Tea
patient will receive twice in a day for 24 weeks
Placebo Jing-Si Herbal Tea
Placebo Jing-Si Herbal Tea
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 20-70
* Diagnosis for moderated NAFLD
* Liver disease without hepatic decompensation
* HbA1c \< = 8.0 %
Exclusion Criteria
* Other related liver diseases will affect the study which evaluated by physicians
* Women of potential pregnancy or pregnant women
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Taichung Tzu Chi Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sheng-Chun Chiu
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Taichung Tzu Chi Hospital
Taichung, Taiwan, Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC110-74
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.